I 
117TH CONGRESS 
1ST SESSION H. R. 4200 
To amend the Omnibus Crime Control and Safe Streets Act of 1968 to 
reauthorize the residential substance use disorder treatment program, 
and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 28, 2021 
Ms. JACKSON LEE (for herself and Mr. JEFFRIES) introduced the following 
bill; which was referred to the Committee on the Judiciary 
A BILL 
To amend the Omnibus Crime Control and Safe Streets 
Act of 1968 to reauthorize the residential substance use 
disorder treatment program, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Residential Substance 
Use Disorder Treatment Act of 2021’’. 
VerDate Sep 11 2014 
23:14 Jul 13, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4200.IH
H4200
kjohnson on DSK79L0C42PROD with BILLS
SEC. 2. RESIDENTIAL SUBSTANCE USE DISORDER TREAT-
MENT PROGRAM. 
(a) AMENDMENTS.—Part S of title I of the Omnibus 
Crime Control and Safe Streets Act of 1968 (34 U.S.C. 
10421 et seq.) is amended— 
(1) in the part heading, by striking ‘‘SUB-
STANCE ABUSE’’ and inserting ‘‘SUBSTANCE USE 
DISORDER’’; 
(2) in section 1901 (34 U.S.C. 10421)— 
(A) in subsection (a)— 
(i) in paragraph (1)— 
(I) by striking ‘‘substance abuse’’ 
each place it appears and inserting 
‘‘substance use disorder’’; and 
(II) by inserting after ‘‘pro-
grams’’ the following: ‘‘, including 
medication-assisted 
treatment 
pro-
grams, which shall be permitted to 
use any type of medication that has 
been approved to treat substance use 
disorders pursuant to section 505 of 
the Federal Food, Drug, and Cos-
metic Act (21 U.S.C. 355), or any 
type of biological product licensed 
under section 351 of the Public 
VerDate Sep 11 2014 
23:14 Jul 13, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4200.IH
H4200
kjohnson on DSK79L0C42PROD with BILLS
Health Service Act (42 U.S.C. 262),’’; 
and 
(ii) in paragraph (3), by striking 
‘‘substance abuse’’ each place it appears 
and inserting ‘‘substance use disorder’’; 
(B) in subsection (b), by striking ‘‘sub-
stance abuse’’ and inserting ‘‘substance use dis-
order’’; and 
(C) in subsection (c)— 
(i) by striking ‘‘part for treatment’’ 
and inserting ‘‘part for— 
‘‘(1) treatment’’; 
(ii) in paragraph (1), as so des-
ignated, by striking the period at the end 
and inserting ‘‘; and’’; and 
(iii) by adding at the end the fol-
lowing: 
‘‘(2) expanding residential substance use dis-
order treatment programs to use not less than 1 
medication or treatment that has been approved to 
treat substance use disorders pursuant to section 
505 of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 355).’’; 
(3) in section 1902 (34 U.S.C. 10422)— 
(A) in subsection (b)— 
VerDate Sep 11 2014 
23:14 Jul 13, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4200.IH
H4200
kjohnson on DSK79L0C42PROD with BILLS
(i) in the subsection heading, by strik-
ing ‘‘ABUSE’’ and inserting ‘‘USE’’; and 
(ii) by striking ‘‘substance abuse’’ 
each place it appears and inserting ‘‘sub-
stance use disorder’’; 
(B) in subsection (c), by striking ‘‘sub-
stance abuse’’ each place it appears and insert-
ing ‘‘substance use disorder’’; 
(C) in subsection (d), by striking ‘‘sub-
stance abuse treatment’’ and inserting ‘‘sub-
stance use disorder treatment’’; 
(D) in subsection (f), by striking ‘‘sub-
stance abuse’’ and inserting ‘‘substance use dis-
order’’; and 
(E) by adding at the end the following: 
‘‘(g) TRAINING REQUIREMENT.— 
‘‘(1) IN GENERAL.—To be eligible to receive 
funds under this part, the chief medical officer of 
the prison or jail or appropriate staff overseeing the 
program shall complete training, before or within a 
reasonable amount of time after receiving the funds, 
on, at a minimum— 
‘‘(A) the science of addiction; 
‘‘(B) the latest research and clinical guid-
ance for detoxification and withdrawal manage-
VerDate Sep 11 2014 
23:14 Jul 13, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4200.IH
H4200
kjohnson on DSK79L0C42PROD with BILLS
ment and the treatment of substance use dis-
orders in criminal justice settings; 
‘‘(C) strategies for continuity of care dur-
ing and after incarceration; 
‘‘(D) an overview of— 
‘‘(i) all medications for the treatment 
of substance use disorders; 
‘‘(ii) how to obtain certification as an 
opioid treatment provider (OTP) or waiv-
ers under the Controlled Substances Act 
(21 U.S.C. 801 et seq.) for prescribing cer-
tain medications; and 
‘‘(iii) evidence-based behavioral thera-
pies used in addition to medication to im-
prove medication adherence and treatment 
outcomes; and 
‘‘(E) any other topic determined by the At-
torney General, in coordination with the Sec-
retary of Health and Human Services and in 
consultation with experts in addiction science, 
to be a core element for successful training 
under this paragraph. 
‘‘(2) REQUIREMENT.—The training required 
under paragraph (1) shall include guidance on how 
to— 
VerDate Sep 11 2014 
23:14 Jul 13, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H4200.IH
H4200
kjohnson on DSK79L0C42PROD with BILLS
‘‘(A) engage relevant stakeholders; 
‘‘(B) identify available resources for, and 
gaps and barriers to, providing residential sub-
stance use disorder treatment; and 
‘‘(C) develop a plan to overcome obstacles 
to administering and offering medication-as-
sisted treatment. 
‘‘(h) PROVIDER AFFILIATION.—Any entity, including 
a prison or jail, that receives Federal funds for a program 
or activity that offers medication-assisted treatment shall 
have an affiliation with a provider that can— 
‘‘(1) prescribe not less than 1 medication-as-
sisted treatment to patients after release from the 
entity; and 
‘‘(2) discuss the risks and benefits of, and alter-
natives to, medication-assisted treatment with pa-
tients.’’; and 
(4) in section 1904 (34 U.S.C. 10424)— 
(A) by amending subsection (c) to read as 
follows: 
‘‘(c) LOCAL ALLOCATION.— 
‘‘(1) IN GENERAL.—Not less than 10 percent of 
the total amount made available to a State under 
subsection (a) for any fiscal year shall be used by 
the State to make grants to local correctional and 
VerDate Sep 11 2014 
23:14 Jul 13, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4200.IH
H4200
kjohnson on DSK79L0C42PROD with BILLS
detention facilities in the State (provided such facili-
ties exist therein). 
‘‘(2) JAIL-BASED SUBSTANCE USE TREATMENT 
PROGRAMS.—A jail-based substance use disorder 
treatment program described in paragraph (1) may 
be made available to any individual who is— 
‘‘(A) awaiting trial or is otherwise in pre- 
trial detention; or 
‘‘(B) serving a sentence of imprisonment in 
the jail.’’; and 
(B) by amending subsection (d) to read as 
follows: 
‘‘(d) EVIDENCE-BASED TREATMENTS.— 
‘‘(1) IN GENERAL.—A State may use amounts 
received under this part to— 
‘‘(A) provide any type of medication-as-
sisted treatment that has been approved to 
treat substance use disorders pursuant to sec-
tion 505 of the Federal Food, Drug, and Cos-
metic Act (21 U.S.C. 355), and any type of bio-
logical product licensed under section 351 of 
the Public Health Service Act (42 U.S.C. 262), 
and prescribe overdose reversal medications 
during the residential substance use disorder 
treatment program or after care; 
VerDate Sep 11 2014 
23:14 Jul 13, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H4200.IH
H4200
kjohnson on DSK79L0C42PROD with BILLS